These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21674)

  • 21. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of the use of a new beta-adrenergic blocker (LB 46) in angina pectoris.
    Aravanis C; Michaelides G
    Acta Cardiol; 1970; 25(5):501-9. PubMed ID: 4395273
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of unstable angina pectoris with maximal medical treatment (combination of intravenous nitrates, beta-blockers, calcium antagonists and heparin).
    Thieuleux FA; Vilarem D; Lablanche JM; Asseman PA; Thery C; Bertrand ME
    Bibl Cardiol; 1985; (39):88-96. PubMed ID: 2877656
    [No Abstract]   [Full Text] [Related]  

  • 25. [Letter: Physiopathology of angina pectoris].
    Loisance DY
    Nouv Presse Med; 1975 Mar; 4(10):745 (2). PubMed ID: 236540
    [No Abstract]   [Full Text] [Related]  

  • 26. [Digitalis and coronary heart disease (author's transl)].
    Schüren KP; Kötter V; Schröder R
    Z Kardiol; 1980 May; 69(5):319-28. PubMed ID: 6109408
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 28. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 29. [Beta-receptor blockader therapy in the acute stage of myocardial infarct pathophysiological basis].
    Jentsch G
    Z Gesamte Inn Med; 1981 Jun; 36(12):401-7. PubMed ID: 6117991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adrenergic beta blocking agents].
    Policlinico Prat; 1969 May; 76(18):584-8. PubMed ID: 4396175
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and efficacy of beta-blockers in the treatment of stable angina pectoris.
    de Muinck ED; Lie KI
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S123-8. PubMed ID: 11527115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of aptine, a new adrenergic beta blockader, in angina pectoris].
    Leduc G; Guiha N
    Union Med Can; 1971 May; 100(5):969-72. PubMed ID: 4147301
    [No Abstract]   [Full Text] [Related]  

  • 33. [Beta-blockers in effort angina].
    Witchitz S; Kolsky H; Moisson P; Philippe B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():87-95. PubMed ID: 6134513
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of metoprolol on systolic time in patients with stable angina pectoris].
    Mosti G; Tomei G; Veltri M; Giusti C
    Minerva Cardioangiol; 1979 Mar; 27(3):147-52. PubMed ID: 37463
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta adrenergic receptor blockaders in treatment of angina pectoris. A critical evaluation].
    Lukasik S; Wrabec K; Stańkowska K; Janicka K
    Pol Tyg Lek; 1973 Jan; 28(1):17-20. PubMed ID: 4405580
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of calcium antagonists on isolated myocardial tissue and their molecular mechanism of action].
    Bayer R; Kaufmann R; Rodenkirchen R; Mannhold R
    Herz; 1982 Aug; 7(4):203-10. PubMed ID: 6127299
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia].
    Zaĭtseva VI; Sharaeva ML
    Vrach Delo; 1988 Dec; (12):15-8. PubMed ID: 2907700
    [No Abstract]   [Full Text] [Related]  

  • 40. [The protective effect of coenzyme Q10 on myocardial metabolism and hemodynamics in open heart surgery].
    Shiguma S; Ohmori H; Kimura H; Sato H; Ozeki M; Sasaki S; Takeuchi A
    Kyobu Geka; 1983 Apr; 36(4):268-71. PubMed ID: 6865135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.